Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:15:26 2024-04-16 pm EDT 5-day change 1st Jan Change
306.6 USD +0.63% Intraday chart for Align Technology, Inc. -7.15% +11.91%
Sales 2024 * 4.05B Sales 2025 * 4.46B Capitalization 22.93B
Net income 2024 * 541M Net income 2025 * 624M EV / Sales 2024 * 5.33 x
Net cash position 2024 * 1.36B Net cash position 2025 * 1.54B EV / Sales 2025 * 4.8 x
P/E ratio 2024 *
42.5 x
P/E ratio 2025 *
36.5 x
Employees 21,610
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.97%
1 week-9.43%
Current month-8.79%
1 month-5.39%
3 months+11.83%
6 months+9.82%
Current year+9.16%
More quotes
1 week
297.64
Extreme 297.64
331.64
1 month
297.64
Extreme 297.64
335.40
Current year
250.28
Extreme 250.28
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer 59 13-12-01
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 65 15-05-31
Director/Board Member 58 Dec. 04
More insiders
Date Price Change Volume
24-04-16 306.6 +0.62% 213 949
24-04-15 304.7 -3.25% 549,893
24-04-12 315 -3.06% 631,737
24-04-11 324.9 -0.89% 515,571
24-04-10 327.8 -0.74% 776,353

Delayed Quote Nasdaq, April 16, 2024 at 10:00 am EDT

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
304.7 USD
Average target price
316 USD
Spread / Average Target
+3.68%
Consensus